If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
6.85    -0.60 (-8.45%)
Bid:
6.70
Ask:
7.00
Spread: 0.30 (4.478%)
Market Cap: £2.85m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Directorate Change

14 Feb 2018 07:00

RNS Number : 8078E
Feedback PLC
14 February 2018
 

This announcement contains inside information as stipulated under the Market Abuse Regulation (EU) No 596/2014 (MAR).

14 February 2018

Feedback plc

 

("Feedback" or the "Company")

 

Directorate change

Appointment of new Chief Executive Officer to drive growth strategy

Cambridge, UK - 14 February 2018: Feedback plc ("Feedback" or the "Company") (AIM: FDBK), the specialist medical imaging technology company, announces that it has appointed David Crabb as Chief Executive Officer and a director of Feedback with immediate effect. This appointment will underpin the execution of the Company's growth strategy following the first CE marked release of TexRAD®; the Company's patented quantitative image texture analysis technology for diagnostic radiological scans.

Mr Crabb brings 20 years of experience as an effective business leader to Feedback. Most recently he was Chief Executive Officer of Cambridge Online Systems, a major software company providing services to UK and international customers, which was acquired by the global IT group Columbus in December 2016. Under Mr Crabb's management in 2011, Cambridge Online Systems delivered strong growth from a loss-making organisation to one with top-quartile financial results and was voted as one of the "Sunday Times Top 100 Companies to work for" in two consecutive years. Previously, Mr Crabb held director-level roles in medium-sized technology and outsourced solutions companies with revenues from £50 million to over £1 billion, responsible for business optimisation, sales and marketing and workforce leadership.

Dr Alastair Riddell, Chairman of Feedback plc, said: "Since the acquisition of Cambridge Computed Imaging Ltd and TexRAD Limited in 2014, Feedback plc has developed a strong reputation in the field of medical imaging and is privileged to be working with over 40 of the world's leading research institutions. We recognise that a small, multi-disciplinary team has its limitations, which resulted in some operational delays over the past 12 months, so I am delighted that Feedback has attracted a highly experienced executive to complement the strong technical and regulatory expertise within the Company. Under David's leadership, we are well-positioned to leverage our pioneering technology to create evidence-based imaging software, arming clinicians with innovative tools to improve patient outcomes."

David Crabb, Chief Executive Officer of Feedback plc, commented: "I am impressed with the platform technologies and domain expertise at Feedback. The medical imaging and diagnostics market is a dynamic, fast-paced environment where disruptive technologies are very much needed. The opportunity is not without its challenges, as with all pioneering development, but as a small, ambitious company which has experienced both acquisition and organic growth, there is significant opportunity to optimise and expand Feedback's operations. Our long-term vision is to lead global innovation in quantitative medical imaging analysis - I believe we have strong foundations to position ourselves at the forefront of this important field and I am looking forward to refining our strategy over the coming months."

Regulatory Disclosures

In accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies, David James Crabb, aged 50 is, or has been within the last five years, a director or partner in the following companies and partnerships: 

Current directorships and partnerships

Past directorships and partnerships held within the last five years

David Crabb Consulting Limited

Cambridge Online Systems Limited

 

There is no other information required to be disclosed under the AIM Rules for Companies.

Notes to editors

About Feedback plc

Feedback plc is a specialist medical imaging technology company. It develops software and systems that provide innovative techniques and improved workflows for practitioners involved in medical research and treating patients. TexRAD®, the Company's patented quantitative image texture analysis technology, has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 40 of the world's leading research institutions across Europe, North America, Asia and Australasia. The Cadran platform provides a suite of medical imaging tools for decision support. The Cadran range includes the picture archiving communication system (PACS) to provide decision support for scan analysis, diagnostic workstations which provide secure remote access to view scans on demand, and products to securely share and transport patient data. Visit www.fbk.com.

 

For further information, please contact:

 Feedback plc

David Crabb, Chief Executive Officer

Lara Mott, Investor Relations

 

Tel: 01954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser and Joint Broker)

David Worlidge / Asha Chotai

Tel: 020 3328 5656

Northland Capital Partners Ltd (Joint Broker)

David Hignell / John Howes

Tel: 020 3861 6625

Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey

Tel: 020 7469 0936

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATJMJTMBABTBP
Date   Source Headline
27th Feb 20157:00 amRNSAttendance at European Congress of Radiology
13th Feb 20157:00 amRNSHalf Yearly Report
20th Nov 201410:59 amRNSResult of AGM
11th Nov 20141:39 pmRNSTexRAD technology assists in medical trials
30th Oct 20149:16 amRNSPosting of Report & Accounts and Notice of AGM
28th Oct 20147:00 amRNSFinal Results
15th Aug 20142:16 pmRNSDirector/PDMR Shareholding
3rd Jul 201412:17 pmRNSDirector/PDMR Shareholding
30th Jun 20148:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:28 pmRNSChange of Registered Office
16th May 201411:18 amRNSResult of EGM
30th Apr 20149:41 amRNSSchedule 1 - Feedback Plc
30th Apr 20147:01 amRNSAcquisitions Subscription and Admission to Trading
6th Mar 20147:00 amRNSChange of Adviser
19th Feb 20147:00 amRNSHalf Yearly Report
13th Jan 20148:00 amRNSDirectorate Change
20th Dec 20137:00 amRNSHolding(s) in Company
12th Dec 20134:08 pmRNSHolding(s) in Company
12th Dec 20134:07 pmRNSHolding(s) in Company
29th Nov 201312:33 pmRNSResult of AGM
20th Nov 20137:00 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSHolding(s) in Company
12th Nov 20137:01 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSFinal Results
30th Jul 201312:18 pmRNSDisposal of freehold property
29th Jul 201310:46 amRNSResult of General Meeting
11th Jul 20137:00 amRNSDisposal of Freehold Property
3rd Jun 20137:00 amRNSDisposal and Director Change
30th May 201310:50 amRNSResult of General Meeting
14th May 20137:00 amRNSDisposal
13th May 20135:37 pmRNSHolding(s) in Company
19th Mar 20137:00 amRNSAdviser Change of Name
25th Feb 20137:00 amRNSFinal Results
30th Nov 201212:48 pmRNSResult of AGM
12th Nov 20127:00 amRNSDirectorate Change
7th Nov 20127:00 amRNSFinal Results
1st Nov 20127:00 amRNSChange of Registered Office
16th Oct 20127:00 amRNSDirectorate Change
23rd May 20123:58 pmRNSDisposal of Feedback Instruments Limited
11th Apr 20126:27 pmRNSForm 8.3 - Feedback Plc
7th Feb 20127:00 amRNSHalf Yearly Report
24th Nov 20117:00 amRNSDirectors' Shareholding
31st Oct 20116:02 pmRNSTotal Voting Rights
19th Oct 20117:00 amRNSDirector's Shareholding
17th Oct 20117:00 amRNSDirectorate Change
14th Oct 20117:00 amRNSGrant of Options
28th Sep 20117:00 amRNSIssue of Equity
2nd Sep 201111:57 amRNSResult of AGM
29th Jul 20117:00 amRNSFinal Results
3rd May 20117:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.